These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3058234)

  • 21. Determination of FDP in human plasma by a novel latex immunoassay.
    Sakai Y; Maeda M; Takei F; Matsumoto T; Nishijima Y; Nakamura K
    Thromb Res; 1988 May; 50(4):469-79. PubMed ID: 3413715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unreliability of current serum fibrin degradation product (FDP) assays.
    Gaffney PJ; Perry MJ
    Thromb Haemost; 1985 Jun; 53(3):301-2. PubMed ID: 3901388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems.
    Hunt FA; Rylatt DB; Hart RA; Bundesen PG
    Br J Haematol; 1985 Aug; 60(4):715-22. PubMed ID: 3896298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
    Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A latex agglutination assay for D dimer: evaluation and application to the diagnosis of thrombotic disease.
    Hillyard CJ; Blake AS; Wilson K; Rylatt DB; Miles S; Bunch R; Elms MJ; Barnes A; Bundesen PG
    Clin Chem; 1987 Oct; 33(10):1837-40. PubMed ID: 3311466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of D Dimer analysis in blood coagulation and fibrinolysis tests].
    Kurokawa I; Kondo H
    Nihon Rinsho; 1989 Dec; 48 Suppl():901-5. PubMed ID: 2695675
    [No Abstract]   [Full Text] [Related]  

  • 27. Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.
    Kudryk BJ; Bini A; Rosebrough SF; Schaible TF
    Biotechnology; 1991; 19():281-313. PubMed ID: 1723912
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of kits for the detection of fibrin(ogen) degradation products in dogs.
    Stokol T; Brooks M; Erb H; Mauldin GE
    J Vet Intern Med; 1999; 13(5):478-84. PubMed ID: 10499733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fully automated immuno-turbidimetric determination of fibrin(ogen) degradation products.
    Hoak DR; Mammen EF; Banerjee SK; Kaldor G
    Thromb Res; 1986 Oct; 44(1):1-10. PubMed ID: 3538493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of a latex test for determining the fibrinogen/fibrin D-dimer (XDP)].
    Barsotti A; Savarino A
    Quad Sclavo Diagn; 1987 Dec; 23(4):421-4. PubMed ID: 3508302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactivities of fibrin(ogen) related antigens and antibodies in radioimmunoassay and latex photometric immunoassay.
    Sudo T; Sawai M
    Nihon Ketsueki Gakkai Zasshi; 1981 Feb; 44(1):131-45. PubMed ID: 7315137
    [No Abstract]   [Full Text] [Related]  

  • 32. Specific identification of fibrin(ogen) degradation products in plasma and serum using blotting and peroxidase labeled antiserum.
    Proietti AB; McGuire M; Bell W
    Am J Hematol; 1990 Aug; 34(4):270-4. PubMed ID: 2195868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of serum fibrinogen and fibrin fragments produced during disseminated intravascular coagulation.
    Lane DA; Preston FE; VanRoss ME; Kakkar VV
    Br J Haematol; 1978 Dec; 40(4):609-15. PubMed ID: 365218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assay of products of fibrin and fibrinogen degradation in disseminated intravascular coagulations. Evaluation of a new technique].
    Borschneck C; Dreyfus M; Bridey F; Edouard D; Meyer D
    Presse Med; 1995 May 6-13; 24(17):799-802. PubMed ID: 7630868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). I. Characterization and preliminary evaluation in plasma.
    Gaffney PJ; Creighton LJ; Perry MJ; Callus M; Thorpe R; Spitz M
    Br J Haematol; 1988 Jan; 68(1):83-90. PubMed ID: 3345297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Critical evaluation of new methods for studying fibrin degradation products].
    Prisco D
    Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis.
    Eisenberg PR; Jaffe AS; Stump DC; Collen D; Bovill EG
    Circulation; 1990 Oct; 82(4):1159-68. PubMed ID: 2119264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the fibrin D-dimer in screening for coagulation abnormalities in preeclampsia.
    Trofatter KF; Howell ML; Greenberg CS; Hage ML
    Obstet Gynecol; 1989 Mar; 73(3 Pt 1):435-40. PubMed ID: 2915868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation, calibration, and specificity of quantitative D-dimer assays.
    Dempfle CE
    Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A monoclonal antibody specific to the granulocyte-derived elastase-fragment D species of human fibrinogen and fibrin: its application to the measurement of granulocyte-derived elastase digests in plasma.
    Kohno I; Inuzuka K; Itoh Y; Nakahara K; Eguchi Y; Sugo T; Soe G; Sakata Y; Murayama H; Matsuda M
    Blood; 2000 Mar; 95(5):1721-8. PubMed ID: 10688830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.